Association between peroxisome proliferator-activated receptor-γ gene polymorphism (Pro12Ala) and Helicobacter pylori infection in gastric carcinogenesis

References

• Lee DS, Moss SF. Targeting Helicobacter pylori in gastric carcinogenesis. Expert Opin Ther Targets 2007;11:757–69.
   PubMed Web of Science ®Google Scholar
• Vieth M, Stolte M. Elevated risk for gastric adenocarcinoma can be predicted from histomorphology [review]. World J Gastroenterol 2006;12:6109–14.
   PubMedGoogle Scholar
• Torres J, Lopez L, Lazcano E, Camorlinga M, Flores L, Munoz O. Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol Biomarkers Prev 2005;14:1874–7.
   PubMed Web of Science ®Google Scholar
• Imrie C, Marion FR, Bourke B, Drumm B. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 2001;107:373–80.
   PubMedGoogle Scholar
• Ando T, Goto Y, Ishiguro K, Maeda O, Watanabe O, Ohmiya N, The interaction of host genetic factors and Helicobacter pylori infection. Inflammopharmacology 2007;15:10–14.
   PubMedGoogle Scholar
• Debril MB, Renaud JP, Fajas L, Auwerx J. The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med 2001;79:30–47.
   PubMed Web of Science ®Google Scholar
• Auwerx J. Nuclear receptors. I. PPAR-γ in the gastrointestinal tract: gain or pain? Am J Physiol Gastrointest Liver Physiol 2002;282:G581–5.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y. Activation of PPAR-γ inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett 1999;455:135–9.
   PubMed Web of Science ®Google Scholar
• Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibits production of monocyte inflammatory cytokines. Nature 1998;391:82–6.
   PubMed Web of Science ®Google Scholar
• Theocharis S, Margeli A, Vielh P, Kouraklis G. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev 2004;30:545–54.
   PubMed Web of Science ®Google Scholar
• Puddu P, Puddu GM, Muscari A. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression? Int J Cardiol 2003;90:133–40.
   PubMedGoogle Scholar
• Girnun GD, Spiegelman BM. PPAR-γ ligands: taking part in chemoprevention. Gastroenterology 2003;124:564–7.
   PubMed Web of Science ®Google Scholar
• Bardot O, Aldridge TC, Latruffe N, Green S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun 1993;92:37–45.
   Google Scholar
• Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T. Peroxisome proliferator-activated receptor-gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 2003;124:361–7.
   PubMed Web of Science ®Google Scholar
• Tsubouchi Y, Sano H, Kawahito Y, Mukai S, Yamada R, Kohno M. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun 2000;270:400–5.
   PubMed Web of Science ®Google Scholar
• Martelli ML, Iuliano R, Le Pera I, Sama I, Monaco C, Cammarota S. Inhibitory effect of peroxisome proliferatoractivated receptor gamma on thyroid carcinoma cell growth. J Clin Endocrinol Metab 2002;87:4728–35.
   PubMed Web of Science ®Google Scholar
• Lu J, Imamura K, Nomura S, Mafune K, Nakajima A, Kadowaki T, Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. Cancer Res 2005;65:4769–74.
   PubMedGoogle Scholar
• Ma XM, Yu H, Huai N. Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma. World J Gastroenterol 2009;15:3874–83.
   PubMedGoogle Scholar
• Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Eur J Endocrinol 2001;144:277–82.
   PubMed Web of Science ®Google Scholar
• Paltoo D, Woodson K, Taylor P, Albanes D, Virtamo J, Tangrea J. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study. Cancer Lett 2003;191:67–74.
   PubMedGoogle Scholar
• Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2005;62:573–9.
   PubMed Web of Science ®Google Scholar
• Memisoglu A, Hu FB, Hankinson SE, Liu S, Meigs JB, Altshuler DM, Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPAR-gamma gene and type 2 diabetes. Diabetes Care 2003;26:2915–17.
   PubMed Web of Science ®Google Scholar
• Koh WP, Yuan JM, Van Den Berg D, Ingles SA, Yu MC. Peroxisome proliferatoractivated receptor (PPAR) gamma gene polymorphisms and colorectal cancer risk among Chinese in Singapore. Carcinogenesis 2006;27:1797–802.
   PubMedGoogle Scholar
• Liao SY, Zeng ZR, Leung WK, Zhou SZ, Chen B, Sung JJ, Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese. Aliment Pharmacol Ther 2006;23:289–94.
   PubMed Web of Science ®Google Scholar
• Tahara T, Arisawa T, Shibata T, Nakamura M, Wang F, Maruyama N, Influence of peroxisome proliferator-activated receptor (PPAR) gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese. Dig Dis Sci 2008;53:614–21.
   PubMedGoogle Scholar
• Prasad KN, Saxena A, Ghoshal UC, Bhagat MR, Krishnani N. Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease. Ann Oncol 2008;19:1299–303.
   PubMedGoogle Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Sugiyama T. Development of gastric cancer associated with Helicobacter pylori infection. Cancer Chemother Pharmacol 2004;54:S12–20.
   Google Scholar
• Leung WK, Bai AH, Chan VY, Yu J, Chan MW, To KF. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells. Gut 2004;53:331–8.
   PubMed Web of Science ®Google Scholar
• Gong Z, Xie D, Deng Z, Bostick RM, Muga SJ, Hurley TG, The PPAR {gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas. Carcinogenesis 2005;26:579–85.
   PubMedGoogle Scholar
• Joo YE, Oh WT, Rew JS, Park CS, Cho SK, Kim SJ. Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathway in gastric carcinogenesis. Digestion 2002;66:222–9.
   PubMed Web of Science ®Google Scholar
• Konturek PC, Kania J, Kukharsky V, Raithel M, Ocker M, Rembiasz K, Implication of peroxisome proliferator-activated receptor γ and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori infection. J Pharmacol Sci 2004;96:134–43.
   PubMed Web of Science ®Google Scholar
• Ricote M, Li AC, Willson TM. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 1998;391:79–82.
   PubMed Web of Science ®Google Scholar